(3-(4-METHYLPIPERAZIN-1-YL)PHENYL)BORONIC ACID PINACOL ESTER, 95.0%, 1g

3-Bromooxetane>95.0%(GC)1g

N-[1-(1H-1,2,3-Benzotriazol-1-yl)butyl]-3-nitroaniline, 250mg

(3,5-dimethylphenyl)acetic acid, 95.0%, 25g

3-(Difluoromethyl)-1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 98%, 250mg

5-Methoxynicotinamide, 98%, 250mg

4-((1,3-Dioxo-1,3-dihydroisobenzofuran-5-yl)oxy)isobenzofuran-1,3-dione, 95.0%, 5g

D(+)-Maltose monohydraté, min 92 %, pour la biochimie, 100 g, emballage plastique.

TERT-BUTYL 3-(4-BROMOPHENYL)-3-FLUOROAZETIDINE-1-CARBOXYLATE, 95.0%, 500mg

2,3-DIHYDRO-1H-INDENE-1-CARBOXAMIDE, 95.0%, 100mg

(2S,3S)-(+)-2,3-Dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one>96.0%(HPLC)(N)25g

Hexane-1,6-diamine dihydrochloride, 95.0%, 500g

1-(1-METHYL-1H-PYRAZOL-4-YL)ETHANAMINE HCL, 95.0%, 250mg